La cadena de opciones muestra datos clave de las opciones de acciones de IF Bancorp a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para IF Bancorp..

IF Bancorp (NASDAQ:IROQ) Bolsa, Cadena de Opciones

IF Bancorp

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.31 per share. This is a 40.91 percent increase over earnings of $0.22 per share from the same period last year. The company reported $6.40 million in sales this quarter. This is a 18.54 percent increase over sales of $5.40 million the same period last year.

Earnings

IF Bancorp Q3 EPS $0.31 Up From $0.22 YoY, Sales $6.40M Up From $5.40M YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.38 per share. This is a 533.33 percent increase over earnings of $0.06 per share from the same period last year.

IF Bancorp Q2 EPS $0.38 Up From $0.06 YoY

Shares of INNOVATE Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) rose sharply in today's <a href="https://www.benzinga.com/quote/VATE">pre-market trading</a>.
INNOVATE announced the FDA approval of MediBeacon&#8217;s TGFR System For accurate kidney function testing.
INNOVATE shares jumped 19.4% to $6.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) gained 89.2% to $1.93 in pre-market trading.</li>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) rose 62.5% to $3.04 in pre-market trading after falling 3% on Friday.</li>
<li>Crown Electrokinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) rose 43.5% to $0.1794 in pre-market trading. Crown Electrokinetics shares jumped around 57% on Friday after the company announced it entered into an exclusive partnership with Electro Scan.</li>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) gained 30.7% to $2.33 in pre-market trading. Trio Petroleum said as of Jan. 7, it has fully repaid senior secured convertible promissory notes with aggregate principal of $1.6 million.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 22.9% to $43.21 in pre-market trading.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) gained 22.8% to $0.9185 in pre-market trading.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) gained 22.6% to $1.63 in pre-market trading.</li>
<li>First Foundation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NYSE">FFWM</a>) gained 12.7% to $7.09 in pre-market trading. First Foundation will release its fourth quarter 2024 earnings results before the opening bell on Thursday, Jan. 30.</li>
<li>Riskified Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) gained 9.2% to $5.49 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) fell 72.3% to $0.3736 in pre-market trading after the company announced Chapter 7 bankruptcy filing, ending operations effective immediately.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) shares fell 30.3% to $0.78 in pre-market trading after dipping 72% on Friday.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) fell 29.4% to $6.14 in pre-market trading after gaining over 5% on Friday.</li>
<li>IF Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) shares dipped 29.4% to $18.00 in pre-market trading after gaining 6% on Friday.</li>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) shares tumbled 19.5% to $14.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares fell 19.4% to $5.10 in pre-market trading.</li>
<li>Baird Medical Investment Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) fell 18.2% to $7.24 in today's pre-market trading after jumping 63% on Friday.</li>
<li>Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) declined 17.1% to $6.24 in pre-market trading</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) fell 16.2% to $50.98 in pre-market trading after the company announced weak quarterly earnings.</li>
<li>SWK Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) dipped 14.3% to $14.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43089042/3m-netflix-and-3-stocks-to-watch-heading-into-tuesday">3M, Netflix And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

Stilwell Activist Investments, L.P. (together with its affiliates, "Stilwell"), one of the largest stockholders of IF Bancorp, Inc. ("IROQ" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>), today issued the following statement in connection with the Company's 2024 Annual Meeting of Stockholders:
At last week's Annual Meeting, stockholders approved our Proposal by a 3:2 margin calling for a prompt sale of IF Bancorp, Inc. Although the Proposal is non-binding, IROQ's stockholders agree that the Company should be sold promptly. We urge IROQ's Board of Directors to&nbsp;act now.
If the stockholder-approved Proposal does not lead to the Company's prompt sale, we intend to seek board representation at IROQ's 2025 annual meeting of stockholders.
The Proposal is copied directly below:
Proposal: RESOLVED, that the stockholders of IF Bancorp, Inc. (the "Company" or "IROQ") hereby recommend that the Board of Directors take all necessary steps to promptly effectuate a sale of the Company.
As set forth in our Supporting Statement included in IROQ's proxy statement filed with the Securities and Exchange Commission on October 16, 2024, we believe that the returns on the Company's assets have been subpar for many years and that IROQ stockholders would be best served if the Company and its assets were sold at the earliest opportunity for the highest price available. The Proposal was submitted pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended.

Management

Stockholders Approve Stilwell Activist Investments Proposal To Sell IF Bancorp; Says 'If The Stockholder-Approved Proposal Does Not Lead To The Company's Prompt Sale, We Intend To Seek Board Representation At IROQ's 2025 Annual Meeting Of Stockholders'

IF Bancorp, Inc. (NASDAQ Capital: IROQ) (the "Company"), and its wholly owned subsidiary, Iroquois Federal Savings and Loan Association (the "Association"), today announced that the Boards of Directors (the "Boards") of the Company and the Association unanimously elected Walter H. Hasselbring, III, the current President and Chief Executive Officer of the Company and the Association, as Chair of the Boards. Mr. Hasselbring succeeds, Gary Martin, who, having reached the age limit established by the Board of Directors in the Company's bylaws, retired from the Boards on November 25, 2024, immediately prior to the Company's Annual Meeting of Stockholders. In conjunction with these changes, Mr. Hasselbring resigned from his position as President of the Company and the Association and the Boards have appointed Thomas J. Chamberlain, current Chief Lending Officer of the Association and Senior Executive Vice President of the Company and the Association, as President of the Company and the Association. Mr. Hasselbring will continue to serve as the Chief Executive Officer of the Company and the Association and continue to oversee their strategic initiatives while Mr. Chamberlain will oversee the day-to-day operations.
In accordance with the Company's Corporate Governance Guidelines and to provide effective oversight and independence of the Boards, the Boards appointed Joseph A. Cowan as Lead Independent Director. Mr. Cowan has served as an independent director of the Company and the Association since 2000.
The Boards have determined that combining the Chair and Chief Executive Officer positions, along with appointing a Lead Independent Director and a new President, is the appropriate structure for the Company and the Association at this time and helps provide strong and consistent leadership for management and the Boards.

IF Bancorp Elects Walter H. Hasselbring, III, The Current President And CEO Of The Company And The Association, As Chair Of The Boards

IF Bancorp Q1 2025 GAAP EPS $0.20 Vs $0.15 YoY

WIIM

CNFR

EWBC

FCNCA

FITB

FNWD

HSBC

Shares of banking and financial services stocks are trading lower in possible sympathy with Ally, which fell after the company's CFO noted credit challenges among borrowers. The sector earlier reacted to Fed Vice Chair for Supervision Barr previewing Basel and GSIB surcharge re-proposals.

BBDO

BBVA

CFBK

CPBI

OPOF

SMFG

VBFC

Shares of banking companies are trading lower amid overall market weakness as investors react to jobs data.

IF Bancorp Q4 EPs $0.13 Down From $0.19 YoY

Shares of Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) rose sharply in today's pre-market trading after the company posted better-than-expected second-quarter results and announced an accelerated $100 million <a href="https://www.benzinga.com/quote/INDV/earnings">share repurchase program</a>.
Indivior reported quarterly earnings of 44 cents per share which beat the analyst consensus estimate of 14 cents per share. The company reported quarterly sales of $299.00 million which beat the analyst consensus estimate of $296.05 million.
Indivior shares jumped 14.5% to $12.46 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Psyence Biomedical Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) rose 157.4% to $1.00 in pre-market trading after the company announced the export of nature-derived psilocybin to Australia and said a trial is projected to be initiated shortly following receipt of drug product by trial sites.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) gained 81.2% to $4.44 in pre-market trading after dipping 43% on Wednesday. BloomZ recently priced its IPO at $4.30 per share.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares climbed 51.4% to $0.4576 in pre-market trading.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) gained 41.5% to $0.2988 in pre-market trading after gaining around 8% on Wednesday.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares gained 20.8% to $60.90 in pre-market trading after the company reported better-than-expected second-quarter EPS results.</li>
<li>Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>) shares gained 15.9% to $0.2231 in pre-market trading after falling over 12% on Wednesday.</li>
<li>Stellus Capital Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCM#NYSE">SCM</a>) shares surged 15.6% to $16.41 in pre-market trading.</li>
<li>ELEVAI Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) gained 15.4% to $0.52 in pre-market trading.</li>
<li>Day One Biopharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) shares gained 7.9% to $16.60 in pre-market trading. Ipsen and Day One entered into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) shares fell 67.7% to $1.33 in pre-market trading. 2U announced a strategic agreement with debtholders to eliminate half of debt and infuse $110 million in new capital.</li>
<li>IF Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) shares declined 59.6% to $6.97 in pre-market trading.</li>
<li>Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) shares fell 22% to $67.85 in pre-market trading after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares fell 19.7% to $0.0367 in pre-market trading after jumping over 75% on Wednesday.</li>
<li>Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares declined 18.7% to $0.36 in pre-market trading after gaining around 19% on Wednesday.</li>
<li>MaxLinear, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NYSE">MXL</a>) shares fell 18.1% to $18.25 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 16.3% to $11.30 in pre-market trading after declining 10% on Wednesday.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) fell 15.9% to $0.8998 in pre-market trading. Hoth Therapeutics shares gained around 11% on Wednesday after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer&#8217;s disease.</li>
<li>Bone Biologics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares dipped 13% to $1.67 in pre-market trading after jumping 54% on Wednesday.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares fell 13% to $11.90 in pre-market trading following a second-quarter earnings miss.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39931967/nvidia-mcdonalds-and-2-other-stocks-insiders-are-selling">Nvidia, McDonald&#8217;s And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

BBLG

BLMZ

CERO

DAWN

ELAB

HOTH

INDV

SLNA

TIVC

TWOU

VKTX

Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.22 per share. This is a 4.76 percent increase over earnings of $0.21 per share from the same period last year.

IF Bancorp Q3 EPS $0.22 Up From $0.21 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.06 per share. This is a 86.05 percent decrease over earnings of $0.43 per share from the same period last year.

IF Bancorp Q2 EPS $0.06 Down From $0.43 YoY

IF Bancorp, Inc.  Q1 EPS $0.14

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.19 per share. This is a 42.42 percent decrease over earnings of $0.33 per share from the same period last year.

IF Bancorp Q4 EPS $0.19 Down From $0.33 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.21 per share. This is a 43.24 percent decrease over earnings of $0.37 per share from the same period last year. The company reported $5.98 million in sales this quarter. This is a 12.68 percent decrease over sales of $6.85 million the same period last year.

IF Bancorp Q3 EPS $0.21 Down From $0.37 YoY, Sales $5.98M Down From $6.85M YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.43 per share. This is a 20.37 percent decrease over earnings of $0.54 per share from the same period last year.

IF Bancorp Q2 EPS $0.43 Down From $0.54 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.62 per share. This is a 1.64 percent increase over earnings of $0.61 per share from the same period last year.

IF Bancorp Q1 EPS $0.62 Up From $0.61 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.33 per share. This is a 3.13 percent increase over earnings of $0.32 per share from the same period last year.

IF Bancorp Q4 EPS $0.33 Up From $0.32 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.54 per share. This is a 12.5 percent increase over earnings of $0.48 per share from the same period last year.

IF Bancorp Q2 EPS $0.54 Up From $0.48 YoY

IF Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) reported quarterly earnings of $0.62 per share. This is a 40.91 percent increase over earnings of $0.44 per share from the same period last year.

IF Bancorp Q1 EPS $0.62 Up From $0.44 YoY

Press Releases

IF Bancorp, Inc. Announces Cash Dividend

IF Bancorp, INC. Announces Results for Fourth Quarter and Fiscal Year Ended June 30, 2024

Stilwell Will Vote in Favor of Proposal to Sell IF Bancorp

Stilwell Will Vote in Favor of Proposal to Sell IF Bancorp - UPDATE

IF Bancorp, Inc. Announces Results for First Quarter of Fiscal Year 2025 (Unaudited)

IF Bancorp, Inc. and Iroquois Federal Savings and Loan Association Announce Appointment of New Board Chair, Lead Independent Director and President

Comments

IF Bancorp

IF Bancorp (IROQ) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL